This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • FBC - anaemia due to blood loss; leukocytosis

  • ESR - increased; correlates with active disease

  • CRP - raised; but less so than in Crohn's disease

  • biochemistry - in active disease, biochemical abnormalities may include hypokalaemia, hyponatraemia, hypomagnesaemia, hypocalcaemia, and hyoalbuminaemia. Abnormal LFTs due to associated chronic active hepatitis - increased ALT - or sclerosing cholangitis - increased alkaline phosphatase

  • ANCA - found in HLA-DR2 associated form of ulcerative colitis

  • radiology:
    • plain abdominal x-ray - excludes toxic dilatation, which is more than 5.5 cm in diameter in adults
    • barium enema:
      • diagnosis of extent and severity of the disease
      • procedure is contraindicated in those patients at risk of a toxic dilatation

  • rectal biopsy - taken at sigmoidoscopy

  • colonoscopy - this is contraindicated in those patients at risk of toxic dilatation. Allows multiple biopsies to be taken throughout the colon and delineation of the extent and activity of the disease

  • white cell scan - allows imaging in severe disease

  • molecular biology - a high intensity of CD44v6 and v3 epitope expression on crypt epithelial cells in patients with UC has been noted. This observation may have diagnostic potential in distinguishing UC from Crohn's

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.